With the emerging advances in utilizing nanocarriers for biomedical applications, a
molecular-level understanding of the in vivo fate of nanocarriers is necessary. After …

Safe and efficient medical therapy for brain diseases is still an unmet clinical need due to
various barriers represented by the blood-brain barrier. Well-designed brain targeted …

For successful translation of targeting nanomedicines from bench to bedside, it is vital to
address their most common drawbacks namely rapid clearance and off-target accumulation …

Nanoparticles-based drug delivery systems have attracted significant attention in biomedical
fields because they can deliver loaded cargoes to the target site in a controlled manner …

The past decade has seen a significant increase in interest in the use of polymeric
nanocarriers in medical applications. In particular, when used as drug vectors in targeted …

Nanoparticles (NPs) can be used to design for nanomedicines with different chemical
surface properties owing to their size advantages and the capacity of specific delivery to …

The protein corona is a natural protein layer spontaneously formed around nanomaterials
when exposed to biological media. This layer can alter the nanosystems' biological …

Nanoparticles (NPs) in contact with a biological medium are rapidly comprehended by a
number of protein molecules resulting in the formation of an NP–protein complex called …

Protein corona is immediately established on the surface of nanoparticles upon their
introduction into biological milieu. Several studies have shown that the targeting efficiency of …

Once introduced into physiological environment, nanoparticles (NPs) are immediately
coated with proteins, resulting in formation of what is known as protein corona. The …